Diagnosis and treatment of hypertensive disorders during pregnancy in Germany. Results of a survey in German obstetric clinics

被引:6
作者
Heilmann, L
Wacker, J
Rath, W
机构
[1] Stadtkrankenhaus Russelsheim, Geburtshilfe & Gynakol Abt, D-65428 Russelsheim, Germany
[2] Furst Stirum Klin, Geburtshilfe & Gynakol Abt, Bruchsal, Germany
[3] Univ Klinikum, Frauenklin Gynakol & Geburtshilfe, Aachen, Germany
关键词
gestational hypertension; preeclampsia; blood changes during preeclampsia; prevention of preeclampsia;
D O I
10.1055/s-2004-820892
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To study the management and treatment of hypertensive disorders during pregnancy in Germany and compare the results with similar surveys. Methods: A multiple choice questionnaire was sent to 717 Departments of Obstetrics/Gynaecology in Germany, of which 34% responded. Results: Most German obstetricians treat women with moderate hypertension of more than 140/95 mmHg in the second trimester with anti-hypertensive drugs based on national protocols in outpatient clinics. First choice drug was methyldopa (46.7%). Thirty-seven percent of obstetricians use beta-blockers and 19.2% dihydralazine per os. 36.8% of obstetricians gave dihydralazine i.v. if blood pressure was 170/110 mmHg or higher. 38.1% of obstetricians prescribed aspirin to patients with moderate or severe hypertension. Many different views existed with respect to severe complications of hypertension such as HELLP syndrome or the treatment of eclamptic convulsions. Thirty-eight percent of obstetricians did not answer the question on how they would treat eclampsia. Conclusions: The management of anti-hypertensive disorders and preeclampsia varies greatly among German obstetricians. This survey indicates that information on individual experiences with treatment regimes together with educational programmes and new treatment modalities for preeclampsia and severe hypertensive complications should be more widely disseminated.
引用
收藏
页码:589 / 599
页数:11
相关论文
共 70 条
[1]  
ACOG, 2002, OBSTET GYNECOL, V99, P869
[2]  
Begum Mosammat Rashida, 2002, Medscape Womens Health, V7, P1
[3]   Hypertension in pregnancy: Maternal and fetal outcomes according to laboratory and clinical features [J].
Brown, MA ;
Buddle, ML .
MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (07) :360-365
[4]   VOLUME HOMEOSTASIS IN NORMAL-PREGNANCY AND PREECLAMPSIA - PHYSIOLOGY AND CLINICAL IMPLICATIONS [J].
BROWN, MA ;
GALLERY, EDM .
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1994, 8 (02) :287-310
[5]   NONPHARMACOLOGICAL MANAGEMENT OF PREGNANCY-INDUCED HYPERTENSION [J].
BROWN, MA .
JOURNAL OF HYPERTENSION, 1990, 8 (04) :295-301
[6]  
BROWN MA, 1993, MED J AUSTRALIA, V158, P700
[7]  
*CAN HYP SOC, 1997, CAN MED ASSOC J, V157, P715
[8]   Low-dose aspirin to prevent preeclampsia in women at high risk [J].
Caritis, S ;
Sibai, B ;
Hauth, J ;
Lindheimer, MD ;
Klebanoff, M ;
Thom, E ;
VanDorsten, P ;
Landon, M ;
Paul, R ;
Miodovnik, M ;
Meis, P ;
Thurnau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :701-705
[9]   HOW OBSTETRICIANS MANAGE HYPERTENSION IN PREGNANCY [J].
CHAMBERLAIN, GVP ;
LEWIS, PJ ;
DESWIET, M ;
BULPITT, CJ .
BRITISH MEDICAL JOURNAL, 1978, 1 (6113) :626-629
[10]   Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: An overview of the evidence from randomised trials [J].
Chien, PFW ;
Khan, KS ;
Arnott, N .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (11) :1085-1091